Japan’s Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim its debt following the US$59 billion purchase of Shire, sources close to the matter told Reuters.
Takeda kicks off sale of Western European drugs: sources
